SpiderRock Advisors LLC Makes New $369,000 Investment in Bruker Co. (NASDAQ:BRKR)

SpiderRock Advisors LLC purchased a new position in Bruker Co. (NASDAQ:BRKR) during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 4,012 shares of the medical research company’s stock, valued at approximately $369,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of BRKR. Rise Advisors LLC purchased a new position in Bruker in the 1st quarter worth about $27,000. Lindbrook Capital LLC grew its stake in Bruker by 68.2% during the 4th quarter. Lindbrook Capital LLC now owns 360 shares of the medical research company’s stock valued at $26,000 after acquiring an additional 146 shares in the last quarter. Neo Ivy Capital Management purchased a new position in Bruker during the 4th quarter valued at about $30,000. GAMMA Investing LLC purchased a new position in Bruker during the 4th quarter valued at about $33,000. Finally, VisionPoint Advisory Group LLC grew its stake in Bruker by 145.0% during the 3rd quarter. VisionPoint Advisory Group LLC now owns 512 shares of the medical research company’s stock valued at $32,000 after acquiring an additional 303 shares in the last quarter. 79.52% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several equities research analysts recently commented on BRKR shares. StockNews.com cut Bruker from a “buy” rating to a “hold” rating in a research note on Tuesday, May 21st. Jefferies Financial Group started coverage on Bruker in a research note on Monday, June 3rd. They issued a “buy” rating and a $85.00 price target for the company. Stifel Nicolaus lowered their price target on Bruker from $81.00 to $77.00 and set a “hold” rating for the company in a research note on Monday, May 20th. The Goldman Sachs Group boosted their price target on Bruker from $66.00 to $74.00 and gave the company a “sell” rating in a research note on Wednesday, April 10th. Finally, Bank of America lowered their price target on Bruker from $95.00 to $90.00 and set a “buy” rating for the company in a research note on Monday, May 20th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, Bruker presently has an average rating of “Moderate Buy” and a consensus target price of $85.00.

Bruker Stock Performance

Shares of BRKR stock traded down $0.37 during trading hours on Friday, reaching $61.46. 373,141 shares of the company’s stock were exchanged, compared to its average volume of 1,000,886. Bruker Co. has a fifty-two week low of $53.79 and a fifty-two week high of $94.86. The business has a fifty day moving average price of $70.02 and a 200-day moving average price of $77.08. The company has a quick ratio of 0.91, a current ratio of 1.81 and a debt-to-equity ratio of 0.95. The stock has a market capitalization of $8.93 billion, a P/E ratio of 22.48, a P/E/G ratio of 2.09 and a beta of 1.20.

Bruker (NASDAQ:BRKR) last released its earnings results on Thursday, May 2nd. The medical research company reported $0.53 earnings per share for the quarter, beating the consensus estimate of $0.46 by $0.07. Bruker had a return on equity of 27.31% and a net margin of 13.38%. The firm had revenue of $721.70 million for the quarter, compared to analyst estimates of $729.88 million. During the same quarter in the prior year, the firm posted $0.64 earnings per share. The company’s quarterly revenue was up 5.3% on a year-over-year basis. Analysts predict that Bruker Co. will post 2.66 EPS for the current fiscal year.

Bruker Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, June 17th. Shareholders of record on Monday, June 3rd were paid a $0.05 dividend. This represents a $0.20 annualized dividend and a yield of 0.33%. The ex-dividend date of this dividend was Monday, June 3rd. Bruker’s payout ratio is 7.27%.

About Bruker

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.